Vivos Therapeutics Inc. (VVOS) Stock Soars Following 510(k) Clearance of mmRNA by U.S FDA
Vivos Therapeutics Inc. (VVOS) stock prices soared by 53.65% as of the market closing on August 23rd 2021. This brought the price per share up to USD$5.90 at the end of the trading day. Subsequent premarket fluctuations saw the stock dip by 5.42%, bringing it down to USD$5.58. VVOS Stock’s 510(k) Approval August 23rd 2021 […]